Cargando…
Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need
The current system of biomedical innovation is unable to keep pace with scientific advancements. We propose to address this gap by reengineering innovation processes to accelerate reliable delivery of products that address unmet medical needs. Adaptive biomedical innovation (ABI) provides an integra...
Autores principales: | Hirsch, G, Trusheim, M, Cobbs, E, Bala, M, Garner, S, Hartman, D, Isaacs, K, Lumpkin, M, Lim, R, Oye, K, Pezalla, E, Saltonstall, P, Selker, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129677/ https://www.ncbi.nlm.nih.gov/pubmed/27626610 http://dx.doi.org/10.1002/cpt.509 |
Ejemplares similares
-
From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients
por: Eichler, H‐G, et al.
Publicado: (2015) -
The next frontier: Fostering innovation by improving health data access and utilization
por: Oye, KA, et al.
Publicado: (2015) -
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms
por: Trusheim, MR, et al.
Publicado: (2016) -
“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?
por: Eichler, H‐G, et al.
Publicado: (2016) -
A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials
por: Selker, H P, et al.
Publicado: (2014)